1.
Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma. jkcvhl [Internet]. 2018 Oct. 8 [cited 2026 Jun. 13];5(4):1-5. Available from: https://jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/109